Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1997-05-22
1999-10-19
Spector, Lorraine
Drug, bio-affecting and body treating compositions
Lymphokine
435 694, 435 695, 4351981, 530399, A61K 3818
Patent
active
059685018
DESCRIPTION:
BRIEF SUMMARY
FIELD OF THE INVENTION
The present invention relates to the use of the hepatocyte growth factor for the preparation of medicaments useful to induce proliferation and differentiation of hematopoietic cells, particularly multipotent and erythroid hematopoietic cell progenitors.
BACKGROUND OF THE INVENTION
Hepatocyte Growth Factor (HGF, the same abbreviation having also been used to define a completely different substance, i.e. hemopoiesis Growth factor) described by Nakamura et al., 1989, and by Hiyazawa et al., 1989), also known as Scatter Factor (Naldini et al., 1991a; Weidner et al., 1991), has the unique feature of combining mitogenic and motogenic activities on its target cells. HGF is mitogenic for hepatocytes (Michalopoulos, 1990) and other epithelial cells, such as kidney tubular epithelium, melanocytes and keratinocytes (Kan et al., 1991; Rubin et al., 1991; Halaban et al., 1992; Matsumoto et al., 1991). In these cells, HGF also promotes "scattering" (Stoker et al., 1987; Gherardi et al., 1989; Weidner et al., 1990, 1991; Naldini et al., 1991a) and matrix invasion (Weidner et al., 1990; Naldini et al., 1991a), and has chemotactic properties (Morimoto et al., 1991; Giordano et al., 1993). The factor stimulates extracellular matrix (ECM) degradation, by enhancing the synthesis of enzymes involved in ECM proteolysis (Pepper et al., 1992; Boccaccio et al., 1994). HGF acts as a morphogen in neuro-ectodermal development in vivo (Stern et al., 1990), and induces three-dimensional organization of epithelial cells in vitro (Montesano et al., 1991). The factor also promotes the progression of carcinoma cells toward malignant invasive phenotypes (Weidner et al., 1990).
The receptor for HGF is the tyrosine kinase encoded by the MET proto-oncogene (Naldini et al., 1991a, 1991b; Bottaro et al., 1991), a 190 kDa heterodimer of an extracellular 50 kDa .alpha. subunit, disulfide-linked to a transmembrane 145 kDa .beta. subunit (Park et al., 1987; Giordano et al., 1989a) Both subunits derive from glycosylation and proteolytic cleavage of a 170 kDa single chain precursor (Giordano et al., 1989b).
The HGF receptor is expressed in adult epithelial tissues, including liver, intestine and kidney (Prat et al., 1991a; Di Renzo et al., 1991). It has been reported to be expressed in early stages of development of epithelial organs (Sonnenberg et al., 1993), and it is often overexpressed in epithelial cancer (Prat et al., 1991a; Di Renzo et al., 1991). We have shown that the receptor is also expressed in endothelial cells and that HGF is a potent angiogenic factor both in vitro and in vivo (Bussolino et al., 1992; Grant et al., 1993). The HGF receptor is also known to be expressed in some populations of blood cells, such as macrophages, but the meaning of such an expression, which is barely detectable in the absence of activation, has not been elucidated (Galini et al., 1993).
EP-A-0,492,614 discloses the use of HGF as a growth enhancer for epitheliocytes, whereas WO 93/08821 discloses the use of HGF for the prevention of the side-effects of chemotherapeuticals.
Now it has been found that the hepatocytes growth factor induces proliferation and differentiation of multipotent and erythroid hematopoietic progenitors.
Hematopoietic cell growth and differentiation is under the control of a complex network of cytokines, which act on their target cells via specific receptors (Metcalf, 1984; Clark and Kamen, 1987). Erythropoiesis is a complex process in which a specific genetic program is primed (commitment) and executed (maturation). Although much is known about maturation, most of the molecular events occurring during the commitment phase are still obscure. Growth and differentiation of erythroid precursor are regulated by humoral factors and by largely uncharacterized cell-cell interactions with bone marrow stroma, the so-called hematopoietic microenvironment. Erythropoietin has long been considered the major factor required for erythropoiesis (Koury and Bondurant, 1990), other factors being far less specific (IL-3, GM-CSF, TGF
REFERENCES:
patent: 5004805 (1991-04-01), Gohda et al.
patent: 5328836 (1994-07-01), Shima et al.
patent: 5328837 (1994-07-01), Godowski et al.
patent: 5459069 (1995-10-01), Palsson et al.
patent: 5599703 (1997-02-01), Davis et al.
Biochemical and Biophisical Research Communications, vol. 194, No. 1 (Jul. 15, 1993), pp. 178-186, K. Mizuno et al, "Hepatocyte Growth Factor Stimulates Growth of Hematopoietic Progenitor Cells".
Experimental Hematology, vol. 22, No. 8 (Aug. 1994), p. 814, XP 000564570, S. Aizawa et al, "Effects of Hepatocyte Growth Factor on Hemopoietic Cells in Human Long-Term Bone Marrow Culture".
Flood, vol. 80 (Nov. 15, 1992), pp. 2454-2457, T. Kmiecik et al, "Hepatocyte Growth Factor is a Synergistic Factor for the Growth of Hematopoietic Progenitor Cells".
Cytokine, vol. 6, No. 3 (May 1994), pp. 285-294, XP 000564568, S. Nakamura et al, "Production of Hepatocype Growth Factor by Human Haematopoietic Cell Lines".
The Journal of Cell Biology, vol. 127, No. 6, Part 1 (Dec. 1994), pp. 1743-1754, XP 000564573, Galimi et al, "Hepatocyte Growth Factor Induces Proliferation and Differentiation of Multipotent etc.".
Blood, vol. 85, No. 11 (Jun. 1, 1995), pp. 3093-3100, XP 000564571, T. Nishino et al, "Hepatocyte Growth Factor as a Hematopoietic Regulator".
Cell Structure and Function, vol. 19, No. 6 (Dec. 1994), p. 543, XP 000564569, K. Takai et al, "Biological Fuction of HGF as a Hematopoietic Factor From Bone Marrow Stromal Cells".
Dompe S.p.A.
Spector Lorraine
LandOfFree
Hepatocyte growth factor--induced proliferation and differentiat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatocyte growth factor--induced proliferation and differentiat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatocyte growth factor--induced proliferation and differentiat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2052057